Copyright
©The Author(s) 2015.
World J Cardiol. Dec 26, 2015; 7(12): 922-930
Published online Dec 26, 2015. doi: 10.4330/wjc.v7.i12.922
Published online Dec 26, 2015. doi: 10.4330/wjc.v7.i12.922
Clinical characteristics of the study population | |
Age (yr) | 70.3 ± 8.3 |
Male (%) | 78.3 |
EF (%) | 27.5 ± 6.5 |
Etiology post-ischemic DC (%) | 63.2 |
Idiopathic DC (%) | 33.7 |
Valvular DC (%) | 2 |
Congenital DC (%) | 1.1 |
NYHA II (%) | 17.3 |
III (%) | 78.6 |
IV (%) | 4.1 |
Optimized pharmacological treatment (%) | 63.21 |
Prevention: Primary (%) | 73.7 |
Secondary (%) | 18.3 |
SVT (%) | 3.7 |
Syncope (%) | 3.2 |
Cardiac arrest (%) | 5.1 |
AF permanent (%) | 16.3 |
Persistent (%) | 7.4 |
Paroxysmal (%) | 4.1 |
Devices: Consulta™ CRT-D | 37.4 |
Concerto™ II CRT-D (%) | 26.3 |
Viva XT™ CRT-D (%) | 22.1 |
Protecta XT™ CRT-D (%) | 14.2 |
Active clinical actions | Partners-HF + | Care alert + |
Pharmacological treatment modification during telephonic contact | ||
Diuretic dosage increase | 120 | 25 |
BB dosage increase | 57 | 22 |
AAD administration | 2 | 2 |
ACE-I and ARA dosage increase | 4 | 0 |
OAC administration | 5 | 5 |
Clinical examination and pharmacological treatment modification | ||
Diuretic dosage increase | 9 | 4 |
BB dosage increase | 8 | 3 |
AAD administration | 1 | 1 |
ACE-I and ARA dosage increase | 1 | 1 |
Anti-platelet administration | 0 | 0 |
Active clinical actions (2-3) | Non-active/no clinical actions (0-1) | Total transmissions | |
Positive partners-HF transmissions | 193 | 35 | 228 |
Negative partners-HF transmissions | 6 | 431 | 437 |
Positive care alert transmissions | 22 | 30 | 52 |
Negative care alert transmissions | 177 | 436 | 613 |
Overall transmissions followed by an action | 199 | 466 | 665 |
Appendix partners-HF algorithm | |||
Parameters | Criterion | ||
Fluid index | ≥ 60 d | ||
AT/AF duration | ≥ 6 h and not persistent AT/AF | ||
VR during AT/AF | AT/AF ≥ 24 h and VR ≥ 90 bpm | ||
Patient activity | < 1 h over 1 wk | ||
NHR | ≥ 85 bpm for 7 consecutive days | ||
HRV | < 60 ms for 7 consecutive days | ||
%CRT pacing | < 90% for 5 of 7 d | ||
Shock (s) | ≥ 1 shock |
- Citation: Calo’ L, Martino A, Tota C, Fagagnini A, Iulianella R, Rebecchi M, Sciarra L, Giunta G, Romano MG, Colaceci R, Ciccaglioni A, Ammirati F, Ruvo E. Comparison of partners-heart failure algorithm vs care alert in remote heart failure management. World J Cardiol 2015; 7(12): 922-930
- URL: https://www.wjgnet.com/1949-8462/full/v7/i12/922.htm
- DOI: https://dx.doi.org/10.4330/wjc.v7.i12.922